MedTrace Logo

Treatment of Myocardial Infarction With Bone Marrow Derived Stem Cells

NCT00275977 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2010-07-23

No results posted yet for this study

Summary

The aim of the study is to investigate whether infusion of autologous bone marrow derived stem cells can improve cardiac function in the aftermath of a myocardial infarction.

Conditions

  • Acute Myocardial Infarction

Interventions

PROCEDURE

Coronary catherization and stem cell infusion

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Moustapha Kassem, MD, Ph.D · Department of endocrinology M, Odense University Hospital

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Completion
2007-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00275977 on ClinicalTrials.gov